Beyond analysts' top -and-bottom-line estimates for Colgate-Palmolive (CL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Colgate-Palmolive achieved over $20 billion in revenue in 2024, driven by strong brand identity, operational discipline, and a diversified product portfolio across Oral Care, Personal Care, Home Care, and Pet Nutrition. The company maintained profitability despite inflation, with a 14.4% margin, and continued to invest in marketing and R&D, enhancing brand differentiation and price stability. Financially robust, Colgate-Palmolive showed significant revenue and margin growth, generating record free cash flow, and is well-positioned for 2025 with a "Buy" rating and a target share price of $100.08.
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
CL drives long-term growth through innovation, digital expansion and sustainability while tackling market challenges with strategic investments and efficiency.
Riskier assets like growth and technology stocks have enjoyed a strong run since early 2023. However, some uncertainty has begun clouding the stock market's outlook.
The Zacks Consumer Products - Staples industry is navigating a tough consumer environment and elevated SG&A costs. Nevertheless, PG, CL, KMB and CLX are leveraging innovations to drive growth.
Fears of a recession make investors actively reposition their portfolios, and defensive companies such as Colgate-Palmolive have non-cyclical characteristics. The company outperforms its peers in terms of profitability, with a strong gross profit margin of over 60% and a high return on total capital of 27.9%. CL stock is valued fairly, with a shareholder value yield above its historical average and a decent price-to-earnings multiple of 25.6x.
Colgate-Palmolive is one of the leaders in the global toothpaste market. On January 31, Colgate-Palmolive released financial results that left me with mixed reactions. Demand for its products in Latin America is growing rapidly, but the strengthening of the US dollar has not allowed Colgate-Palmolive to fully reflect this in its EPS.
Colgate-Palmolive Company (NYSE:CL ) UBS Global Consumer and Retail Conference Call March 12, 2025 3:00 PM ET Company Participants John Faucher - Chief Investor Relations Officer and EVP, M&A Conference Call Participants Peter Grom - UBS Peter Grom All right. Good afternoon, everyone.
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
The stock market is selling off, with Canada and China retaliating against President Donald Trump's tariffs , and Mexico promising to announce its response on Sunday.